STEMLINE THERAPEUTICS INC (STML) [Rocket]

In millions, except per share items	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16	Dec-31-15	Dec-31-14	Dec-31-13	Dec-31-12
	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K
Cash flows from operating activities
Net loss	-76.8	-85.0	-67.8	-38.3	-37.2

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization expense	0.1	0.1	0.0
Stock-based compensation expense	26.2	13.9	8.6	7.4	5.2	4.4	4.8	0.6
Stock award - in-licensing	0.5
Employee Stock Purchase Plan compensation expense	0.3	0.1	0.1	0.1	0.1
Non-cash lease expense	1.0
Unrealized foreign exchange loss	0.0
Net loss on sale of marketable securities	0.0	0.0	0.0
Changes in operating assets and liabilities:
Accounts receivable, net	-15.1
Inventories, net	-0.9
Other assets	-0.1			-0.2
Prepaid expenses and other current assets	-1.5	-2.5	-0.2	0.4	1.0	-1.3	0.0	-0.1
Accounts payable and accrued expenses	0.8	1.4	10.5	0.7	5.0	-0.5	2.2	1.6
Operating lease liabilities	-1.0
Other liabilities	0.0	0.0	0.0	0.1	0.0
Net cash used in operating activities	-67.7	-72.2	-49.6	-30.1	-25.6	-25.7	-16.1	-4.1

Cash flows from investing activities
Purchase of marketable securities				-26.5	-105.6	-16.2	-40.2
Sale and maturities of marketable securities				53.1	54.7	22.6
Net cash provided by (used in) investing activities	-99.2	10.8	-4.4	26.7	-50.9	6.4	-40.7

Cash flows from financing activities
Proceeds from issuance of common stock from follow-on public offering, net	168.4	63.9	48.2		64.1		97.7
Proceeds from issuance of common stock from ESPP	0.4	0.2	0.2	0.1	0.0
Proceeds from exercise of stock options	2.1	1.6	0.1	0.3	0.7	0.1	1.3
Net cash provided by financing activities	171.0	66.0	48.5	0.4	64.9	0.1	99.0	0.3